Does PALBOCICLIB Cause Gastrointestinal motility disorder? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Gastrointestinal motility disorder have been filed in association with PALBOCICLIB (Ibrance). This represents 0.0% of all adverse event reports for PALBOCICLIB.
35
Reports of Gastrointestinal motility disorder with PALBOCICLIB
0.0%
of all PALBOCICLIB reports
2
Deaths
8
Hospitalizations
How Dangerous Is Gastrointestinal motility disorder From PALBOCICLIB?
Of the 35 reports, 2 (5.7%) resulted in death, 8 (22.9%) required hospitalization.
Is Gastrointestinal motility disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Gastrointestinal motility disorder?
ADALIMUMAB (207)
LEVOTHYROXINE (191)
LENALIDOMIDE (188)
POLYETHYLENE GLYCOL 3350 (163)
LINACLOTIDE (130)
CABOZANTINIB S-MALATE (98)
VEDOLIZUMAB (78)
CARBIDOPA\LEVODOPA (70)
SERTRALINE (65)
INFLIXIMAB (61)
Which PALBOCICLIB Alternatives Have Lower Gastrointestinal motility disorder Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID